Health.Zone Web Search

  1. Ads

    related to: parkinson's progression markers initiative (ppmi) 1

Search results

  1. Results from the Health.Zone Content Network
  2. Parkinson's Progression: 6 Signs to Look For - Healthline

    www.healthline.com/health/parkinsons/treatments/...

    6 Signs Your Parkinson’s Disease Is Progressing. Medication not working. Anxiety and depression. Changing sleeping patterns. Involuntary movements. Trouble swallowing. Memory problems. Takeaway ...

  3. The Michael J. Fox Foundation - Wikipedia

    en.wikipedia.org/wiki/The_Michael_J._Fox_Foundation

    In 2023, a longitudinal study funded by the organization, the Parkinson's Progression Markers Initiative, released results in Lancet Neurology showing Parkinson's can be detected by the presence of a biomarker protein, abnormal alpha-synuclein. The biomarker can be detected before the onset of symptoms.

  4. Alzheimer's Disease Neuroimaging Initiative - Wikipedia

    en.wikipedia.org/wiki/Alzheimer's_Disease...

    Alzheimer's Disease Neuroimaging Initiative. Alzheimer's Disease Neuroimaging Initiative ( ADNI) is a multisite study that aims to improve clinical trials for the prevention and treatment of Alzheimer's disease (AD). [1] This cooperative study combines expertise and funding from the private and public sector to study subjects with AD, as well ...

  5. Types of Parkinson's and How They're Diagnosed - Healthline

    www.healthline.com/health/parkinsons/types-of...

    A doctor trained in neurogenerative conditions diagnoses Parkinson’s based on your symptoms, medical history, and results from a physical and neurological test. No single test can diagnosis ...

  6. Parkinson's MRI: Diagnosing Early Onset Through Brain Imaging

    www.healthline.com/health/parkinsons/parkinsons-mri

    Parkinson’s treatments aim to minimize symptoms and slow down progression. Treatment plans will take into account such factors as symptoms, overall health, and response to treatment.

  7. Michael J. Fox - Wikipedia

    en.wikipedia.org/wiki/Michael_J._Fox

    Since 2010, he has led a $100-million effort, which is the Foundation's landmark observational study, to discover the biological markers of Parkinson's disease with the Parkinson's Progression Markers Initiative (PPMI). Fox manages the symptoms of his Parkinson's disease with the drug carbidopa/levodopa, and he had a thalamotomy in 1998.

  1. Ads

    related to: parkinson's progression markers initiative (ppmi) 1